Tu Y, Wang C, Xu S, Lan Z, Li W, Han J, Zhou Y, Zheng P, Zhu W (2017) Design, synthesis, and

docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR

inhibitors. Bioorg Med Chem 25(12):3148–3157

Voigtlaender M, Schneider-Merck T, Trepel M (2018) Lapatinib. Recent Results Cancer Res 211:

19–44

Wecker H, Waller CF (2018) Afatinib. Recent Results Cancer Res 211:199–215

Wu X, Chi X, Wang P, Zheng D, Ding R, Li Y (2010) The evolutionary rate variation among genes

of HOG-signaling pathway in yeast genomes. Biol Direct 5(1):46

Yarden Y, Schlessinger J (1987) Epidermal growth factor induces rapid, reversible aggregation of

the purified epidermal growth factor receptor. Biochem 26(5):1443–1451

Zhang HQ, Gong FH, Ye JQ, Zhang C, Yue XH, Li CG, Xu YG, Sun LP (2017) Design and

discovery of 4-anilinoquinazoline-urea derivatives as dual TK inhibitors of EGFR and

VEGFR-2. Eur J Med Chem 125:245–254

Zheng YG, Su J, Gao CY, Jiang P, An L, Xue YS, Gao J, Liu Y (2017) Design, synthesis, and

biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as

potential EGFR kinase inhibitors. Eur J Med Chem 130:393–405

Zou M, Jin B, Liu Y, Chen H, Zhang Z, Zhang C, Zhao Z, Zheng L (2019) Synthesis and biological

evaluation of some novel thiophene-bearing quinazoline derivatives as EGFR inhibitors. Lett

Drug Des Discov 16(2):102–110

21

EGFR-Targeted Quinazoline Clubbed Heterocycles as Anticancer Agents

399